Italia markets closed
FTSE MIB
33.154,05 -32,84 (-0,10%) Dow Jones
39.118,86 -45,20 (-0,12%) Nasdaq
17.732,60 -126,08 (-0,71%) Nikkei 225
39.583,08 +241,54 (+0,61%) Petrolio
81,46 -0,28 (-0,34%) Bitcoin EUR
56.649,68 -1.065,07 (-1,85%)
GSK plc (G1SK34.SA)
São Paulo - São Paulo Prezzo differito. Valuta in BRL.
Aggiungi a watchlist
Alla chiusura: 02:16PM BRT
| Chiusura precedente | 42,50 |
| Aperto | 42,50 |
| Denaro | 40,70 x N/D |
| Domanda | 47,00 x N/D |
| Min-Max giorno | 42,50 - 43,35 |
| Intervallo di 52 settimane | 32,88 - 47,00 |
| Volume | |
| Media Volume | 67 |
| Capitalizzazione | 442,66B |
| Beta (mensile su 5 anni) | 0,27 |
| Rapporto PE (ttm) | 5,71 |
| EPS (ttm) | 7,59 |
| Prossima data utili | 31 lug 2024 |
| Rendimento e dividendo (futuro) | 1,56 (3,66%) |
| Data ex dividendo | 16 mag 2024 |
| Stima target 1A | N/D |
GlobeNewswireGlobal CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines. The CAR T-cell therapy market is currently going through a rapid expansion, owing to rapidly expanding clinical trial activities and recent commercialization of CAR-T cell therapy, whic
© 2024 Yahoo. Tutti i diritti riservati.